Viewing nowMontelukast Sodium Orally Disintegrating Tablet 10 mg (Montelukast Sodium)
Montelukast Sodium 10.4mg
Orally disintegrating Tablet · Prescription medication
Ildong Pharmaceutical Co., Ltd.

MFDS item code 201202801 · Approved 2012.04.10 · Insurance code 642904370
Effectiveness in preventing asthma and alleviating symptoms of allergic rhinitis
This medication helps to prevent the occurrence of asthma and manage it continuously. It is also used to relieve symptoms of allergic rhinitis, whether seasonal or persistent throughout the year, thereby improving the quality of life for patients.
Adults and adolescents aged 15 and older should place 10 mg of montelukast under the tongue to dissolve and take without water once daily. Asthma patients should take one tablet daily in the evening. Allergic rhinitis patients should determine the dosing time based on their condition. Patients with both asthma and allergic rhinitis should take one tablet daily in the evening.
This medication should not be administered to patients with phenylketonuria. The artificial sweetener aspartame contained in this medication is broken down into phenylalanine in the body, which can be harmful to those with this condition. Additionally, since this medication contains lactose, individuals with genetic disorders such as galactose intolerance, lactase deficiency, or glucose-galactose malabsorption should avoid taking it. This medication is not for use during acute asthma attacks; appropriate emergency medication should be used during acute symptoms, and this medication should be taken regularly even when asthma symptoms are absent. During treatment, neuropsychiatric symptoms such as anxiety, depression, hallucinations, or behavioral changes may occur, and if such symptoms arise, medical consultation should be sought immediately. Individuals with hypersensitivity to aspirin or non-steroidal anti-inflammatory drugs should avoid taking these medications while using this drug, and those with exercise-induced asthma should not use this medication alone but in conjunction with inhaled bronchodilators. During pregnancy or breastfeeding, use should be discussed with a physician as needed, and caution should also be exercised when prescribing to children or the elderly. In the event of an overdose, no specific antidote exists, so treatment should be directed by a physician based on symptoms, and since this medication is sensitive to light, it should be taken immediately after preparation. Finally, keep this medication out of the reach of children and avoid transferring it to other containers.
Hives, angioedema, toxic epidermal necrolysis, Stevens-Johnson syndrome, severe allergic reactions, severe skin reactions, breathing problems, vasculitis rash, exacerbation of pulmonary symptoms, cardiac complications, neuropathy, suicidal thoughts and behaviors, suicidal tendencies, seizures, convulsive seizures, liver abnormalities (increased ALT, increased AST, cholestatic hepatitis, hepatocellular damage, mixed liver injury, jaundice), severe swelling, edema
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to protect it from exposure to air, moisture, and light. Maintaining a storage temperature between 1 and 30 degrees Celsius is important to ensure the drug's efficacy and to prevent deterioration.
White to off-white, rounded square orally disintegrating tablet
28 tablets/box [(7 tablets/Alu-Alu) x 4]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowMontelukast Sodium 10.4mg
Orally disintegrating Tablet · Prescription medication
Ildong Pharmaceutical Co., Ltd.

Montelukast Sodium 5.2mg
Chewable Tablet · Prescription medication
Korea Organon Co., Ltd.

Montelukast Sodium 10.4mg
Tablet · Prescription medication
Korea Organon Co., Ltd.

Montelukast Sodium 4.16mg
Chewable Tablet · Prescription medication
Korea Organon Co., Ltd.
Montelukast Sodium 4.16mg
Prescription medication
Korea Organon Co., Ltd.

Montelukast Sodium 10.4mg
Tablet · Prescription medication
JW Pharmaceutical Co., Ltd.

Montelukast Sodium 4.16mg
Chewable Tablet · Prescription medication
Youngjin Pharmaceutical Co., Ltd.

Montelukast Sodium 4.16mg
Chewable Tablet · Prescription medication
Samil Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.